CY1105732T1 - Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα - Google Patents

Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα

Info

Publication number
CY1105732T1
CY1105732T1 CY20061101534T CY061101534T CY1105732T1 CY 1105732 T1 CY1105732 T1 CY 1105732T1 CY 20061101534 T CY20061101534 T CY 20061101534T CY 061101534 T CY061101534 T CY 061101534T CY 1105732 T1 CY1105732 T1 CY 1105732T1
Authority
CY
Cyprus
Prior art keywords
dietary supplement
disclosed
calcium
composition
phosphorus
Prior art date
Application number
CY20061101534T
Other languages
English (en)
Inventor
Hector F. Deluca
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27042788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105732(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/469,513 external-priority patent/US6160016A/en
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of CY1105732T1 publication Critical patent/CY1105732T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Μια σύνθεση μυρμηκικού ασβεστίου για στοματική χορήγηση σε ένα άτομο για τον σκοπό της αναστολής γαστρεντερικής απορρόφησης του φωσφόρου γνωστοποιείται. Μια μέθοδος αναστολής της γαστρεντερικής απορρόφησης του φωσφόρου, η οποία περιλαμβάνει τη χορήγηση στοματικά της σύνθεσης, κατά προτίμηση σε χρόνο κοντινό στην κατανάλωση τροφής και ποτού γνωστοποιείται επίσης. Μια σύνθεση μυρμηκικού ασβεστίου για στοματική χορήγηση σε ένα άτομο για το σκοπό συμπληρωματικού διαιτητικού ασβεστίου επίσης γνωστοποιείται.
CY20061101534T 1999-12-22 2006-10-24 Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα CY1105732T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/469,513 US6160016A (en) 1999-12-22 1999-12-22 Phosphorus binder
US09/649,710 US6489361B1 (en) 1999-12-22 2000-08-25 Phosphorus binder
PCT/US2000/034869 WO2001045695A2 (en) 1999-12-22 2000-12-21 Calcium formate for use as a phosphorus binder and a dietary supplement

Publications (1)

Publication Number Publication Date
CY1105732T1 true CY1105732T1 (el) 2010-12-22

Family

ID=27042788

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101534T CY1105732T1 (el) 1999-12-22 2006-10-24 Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα

Country Status (11)

Country Link
US (10) US20010016603A1 (el)
EP (1) EP1242067B1 (el)
JP (1) JP2003518058A (el)
AT (1) ATE333871T1 (el)
AU (1) AU782649B2 (el)
CA (1) CA2395530C (el)
CY (1) CY1105732T1 (el)
DE (1) DE60029628T2 (el)
DK (1) DK1242067T3 (el)
ES (1) ES2269218T3 (el)
WO (1) WO2001045695A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045695A2 (en) * 1999-12-22 2001-06-28 Wisconsin Alumni Research Foundation Calcium formate for use as a phosphorus binder and a dietary supplement
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060029641A1 (en) * 2004-08-05 2006-02-09 Keller Nathan I Calcium and magnesium nutritional supplement
WO2006044657A2 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
CA2619643A1 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
EP2252274A4 (en) * 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
WO2011143475A1 (en) 2010-05-12 2011-11-17 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US20160053281A1 (en) 2013-08-15 2016-02-25 The University Court Of The University Of Edinburgh Enhanced Expression Of RNA Vectors

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191835A (en) * 1936-09-24 1940-02-27 Allentown Marjorie G Snelling Food process and product
US2266992A (en) 1939-03-15 1941-12-23 American Cyanamid Co Therapeutic composition
US2471144A (en) * 1948-12-02 1949-05-24 Sterling Drug Inc Salt substitute
US2596333A (en) * 1951-04-03 1952-05-13 Fougera & Co Inc E Dietary salt substitute
US3558786A (en) 1963-08-15 1971-01-26 Geigy Chem Corp Feed composition and its utilization
US3709696A (en) * 1971-05-06 1973-01-09 Barrera R Tortilla and process using hydrophilic inorganic gels
FR2196151A1 (en) 1972-08-18 1974-03-15 Grimberg George Dietetic sodium-free salt mixture - for use by patients with renal insuffic--iency or hypertension
CA1066617A (en) 1975-11-27 1979-11-20 John J. Huitson Liquid composition containing formic acid
JPS589663B2 (ja) * 1976-06-30 1983-02-22 キッコーマン株式会社 醸造食品の製造法
JPS59154053A (ja) 1983-02-22 1984-09-03 Takeshi Amakawa 半導体成形品におけるリ−ド折曲方法及び装置
US4851221A (en) * 1985-02-19 1989-07-25 Mission Pharmacal Company Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
DE3628249C1 (de) * 1986-08-20 1987-11-26 Degussa Mittel zur Verbesserung des Wachstums und der Futterverwertung bei Schweinen
US4870105B1 (en) * 1987-04-07 1998-03-10 Braintree Lab Phosphorus binder
DK159807C (da) * 1989-02-27 1992-06-29 Gunnar Kjems Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
EP0509707A1 (en) * 1991-04-08 1992-10-21 Petrella Limited 0-40% fat spread
PH31657A (en) * 1992-02-13 1999-01-12 Shiao Shin Jen Areca food additives and its foods.
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5589197A (en) 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution
US6159503A (en) * 1993-12-02 2000-12-12 Hercules Incorporated Pectin process and composition
DE4402544C2 (de) * 1994-01-28 1996-01-18 Chevita Gmbh Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
CA2122863C (en) * 1994-05-04 1997-05-20 Jacques Jalbert Animal food supplement briquette
US5637312A (en) * 1995-03-29 1997-06-10 Tock; Richard W. Digestion enhancer for ruminant animals comprising a formate salt
US5698222A (en) 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
US5645853A (en) * 1995-08-08 1997-07-08 Enamelon Inc. Chewing gum compositions and the use thereof for remineralization of lesions in teeth
US5571502A (en) * 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth
GB9603518D0 (en) * 1996-02-20 1996-04-17 Smithkline Beecham Plc Novel process
US5945144A (en) * 1996-07-08 1999-08-31 Hahn; David H. Calcium fortified pasta and process of making
EA199900194A1 (ru) * 1996-09-12 1999-12-29 Бичем Консьюмер Хелткер Гмбх Смитклайн Реминерализующая композиция
US5817296A (en) * 1996-09-27 1998-10-06 Enamelon, Inc. Processes and compositions for the remineralization of teeth
US5958380A (en) * 1997-07-07 1999-09-28 Enamelon, Inc. Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules
DE19753321A1 (de) * 1997-12-02 1999-06-10 Basf Ag Verfahren zur Herstellung und Verwendung von Lysinformiat
US5905093A (en) 1998-02-17 1999-05-18 Nadia Achkar Fish scale extract as a calcium supplement
US6303104B1 (en) * 1999-02-12 2001-10-16 Enamelon, Inc. Remineralizing/mineralizing oral products having improved whitening and stain removal properties
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
WO2001045695A2 (en) * 1999-12-22 2001-06-28 Wisconsin Alumni Research Foundation Calcium formate for use as a phosphorus binder and a dietary supplement

Also Published As

Publication number Publication date
US6528542B2 (en) 2003-03-04
US20140155360A1 (en) 2014-06-05
CA2395530A1 (en) 2001-06-28
US20110059927A1 (en) 2011-03-10
ES2269218T3 (es) 2007-04-01
AU2448501A (en) 2001-07-03
EP1242067B1 (en) 2006-07-26
US20020035151A1 (en) 2002-03-21
DE60029628T2 (de) 2007-07-26
US20170246206A1 (en) 2017-08-31
US20040029964A1 (en) 2004-02-12
WO2001045695A3 (en) 2002-01-03
US7850991B2 (en) 2010-12-14
US20120046252A1 (en) 2012-02-23
WO2001045695A2 (en) 2001-06-28
ATE333871T1 (de) 2006-08-15
DE60029628D1 (de) 2006-09-07
EP1242067A2 (en) 2002-09-25
DK1242067T3 (da) 2006-11-27
US20030100609A1 (en) 2003-05-29
JP2003518058A (ja) 2003-06-03
CA2395530C (en) 2008-07-15
US20050106234A1 (en) 2005-05-19
US20170049808A1 (en) 2017-02-23
US20010016603A1 (en) 2001-08-23
AU782649B2 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
CY1105732T1 (el) Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα
AR025925A1 (es) UNA COMPOSICIoN PARA UNA FORMULACIoN INFANTIL, UN MÉTODO PARA PRODUCIRLA Y SU USO PARA LA FABRICACIoN DE UN MEDICAMENTOS O UN PRODUCTO NUTRICIONAL DIRIGIDO A LA MALNUTRICION.
WO2002043659A3 (en) Composition containing statins and calcium for improved cardiovascular health
CY1111313T1 (el) Σταθερο κρυσταλλικο αλας του 5-μεθυλο-(6s)-τετραϋδροφολικου οξεος
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
DK0575846T3 (da) Lipasehæmmerholdige næringsmidler og foderstoffer
EA199800861A1 (ru) Твердая лекарственная форма, содержащая производные цизаприда, способ ее получения, продукт, содержащий твердую лекарственную форму, фармацевтическая упаковка
AU2003245947A1 (en) Use of alkylamidomandelates as flavourings
NO20061834L (no) Diett supplement omfattende kalsium
RU2009115791A (ru) Смесь солей железа и меди, маскирующая металлический вкус
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
AR035652A1 (es) Una composicion nutricional, util para combatir la infeccion en el tracto gastrointestinal causada por organismos tipo helicobacter, el uso de dicha composicion para la preparacion de medicamentos, o productos alimenticios y el procedimiento para preparar dicha composicion
DK1063901T3 (da) Næringsmidler, som indeholder biotin og andre B-vitaminer
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
BR0213449A (pt) Comprimido mastigável contendo lisina
PT979224E (pt) Composicoes solidas adequadas para administracao oral compostas por l-carnitina ou alcanoil-l-carnitina fuarato de magnesio
TW200517140A (en) Multivitamin syrup for children or young adults
EP1306367A4 (en) SULFONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE AS MEDICAL PRODUCTS
ATE217494T1 (de) Orale darreichungsform
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
PL367812A1 (en) Alpha-ketoglutarates of active ingredients and compositions containing same
HUP0302294A2 (hu) L-karnitin és alkanoil-L-karnitin taurin-kloriddal és glicin-kloriddal alkotott nem higroszkópos sói és ezeket tartalmazó, orális beadásra alkalmas szilárd készítmények
PT971879E (pt) Composicoes solidas adequadas para administracao oral compreendendo l-carnitino e alcanoil.l.carnitino tartarato de magnesio
PT1289931E (pt) Sais duplos de acido fumarico com uma carnitina e um aminoacido e suplementos alimentares, suplementos dieteticos e farmacos contendo os mesmos
PT975581E (pt) Composicoes solidas adequadas para administracao oral compreendendo tartarato de l-carnitina e colina ou de alcanoil-l-carnitina e colina